Acute chest pain is a common, yet challenging symptom faced by healthcare professionals. It can manifest from benign causes to life-threatening conditions, making its diagnosis a critical task. This article aims to provide a comprehensive approach to deciphering the enigma of acute chest pain.
Acute chest pain can be due to cardiovascular, respiratory, gastrointestinal, musculoskeletal, or psychological causes. The most alarming is acute coronary syndrome (ACS), which requires immediate attention. Other cardiovascular causes include pericarditis and aortic dissection. Pulmonary embolism and pneumothorax are primary respiratory causes, while gastrointestinal causes include gastroesophageal reflux disease (GERD) and peptic ulcer disease. Musculoskeletal and psychological causes are often overlooked but should be considered.
A thorough history and physical examination are paramount. The character, onset, location, duration, exacerbating and relieving factors of the pain provide crucial diagnostic clues. Physical examination should include vital signs, cardiac and lung auscultation, and abdominal and musculoskeletal examination. Risk factors for coronary artery disease should be assessed.
Initial investigations should include an electrocardiogram (ECG) and cardiac biomarkers. Chest radiography, computed tomography (CT) scan, or echocardiography may be needed based on the clinical suspicion. Further testing like coronary angiography may be warranted in cases of suspected ACS.
Management depends on the underlying cause. ACS requires immediate revascularization, while other conditions may need medical or surgical interventions. Pain relief is crucial, irrespective of the cause. Patient education about the nature of their condition and lifestyle modifications also play a significant role.
Deciphering acute chest pain requires a comprehensive, systematic approach. Understanding the wide range of possible etiologies, thorough clinical evaluation, appropriate diagnostic testing, and targeted management strategies are key to optimal patient outcomes. As healthcare professionals, it is our duty to unravel this enigma and ensure the best care for our patients.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation